化学抗原受体T细胞的发展,以向癌症表达型 podocalyxin 的 T 细胞
Yuta Mishima1,2, Shintaro Okada3, Akihiro Ishikawa3
1Department of Cancer Immunotherapy and Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Regenerative therapy
|January 27, 2025
概括
这项研究使用CasMab技术开发了针对癌症的化学抗原受体 (CAR) -T细胞,以向podocalyxin (PODXL). 这些新型CAR-T细胞在固体瘤治疗中显示出更高的安全性和有效性.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法已经改变了B细胞恶性瘤治疗.
- 波多卡利辛 (PODXL) 是一种与癌症进展和不良预后相关的跨膜蛋白.
- 现有的CAR-T疗法在有效和安全地向固体瘤方面面临挑战.
研究的目的:
- 利用癌症特异单克隆抗体 (CasMab) 技术,探索针对PODXL的CAR-T细胞的潜力.
- 提高CAR-T细胞治疗固体瘤的特异性和安全性.
- 为了评估人性化的CAR-T细胞的治疗疗效和持久性.
主要方法:
- 使用针对PODXL的癌症特异性 (PcMab-6) 和非特异性 (PcMab-47) 抗体的单链可变片段 (scFvs) 开发的CAR-T细胞.
- 进行了体外实验,以评估抗瘤活性和非目标效应.
- 生成并测试了人性化的CAR-T细胞,以检测体内持久性和治疗疗效.
主要成果:
- 来自PCMab-6的CAR-T细胞在体外表现出显著的抗瘤活性.
- 与PcMab-47对照组相比,PcMab-6 CAR-T细胞对正常细胞的脱效应减少.
- 人性化的PcMab-6 CAR-T细胞在体内表现出延长的抗瘤作用,表明持续性增强.
结论:
- 卡斯马布 (CasMab) 技术使得在固体瘤中产生高特异性和更安全的CAR-T细胞疗法成为可能.
- 人性化PODXL向的CAR-T细胞有望延长治疗活性和临床应用.
- 这种方法代表了CAR-T细胞治疗具有挑战性的癌症的重大进展.
更多相关视频
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.1K
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
11.6K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466